Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Rectovaginal Fistula : Article by

Quick Find
Authors & Editors
Introduction
Indications
Relevant Anatomy
Contraindications
Workup
Treatment
Complications
Outcome and Prognosis
Future and Controversies
References




Patient Education
Click here for patient education.



Author: Carol E H Scott-Conner, MD, PhD, Professor, Department of Surgery, University of Iowa College of Medicine

Carol E H Scott-Conner is a member of the following medical societies: American Association for Cancer Research, American Association for the Surgery of Trauma, American Burn Association, American Cancer Society, American College of Gastroenterology, American College of Surgeons, American Medical Association, American Society for Gastrointestinal Endoscopy, Association for Academic Surgery, Association for Surgical Education, Association of VA Surgeons, Iowa Medical Society, Sigma Xi, Society for Surgery of the Alimentary Tract, Society of American Gastrointestinal and Endoscopic Surgeons, Society of Critical Care Medicine, Society of Surgical Oncology, Society of University Surgeons, and Southeastern Surgical Congress

Coauthor(s): Jan Rakinic, MD, Chief, Section of Colorectal Surgery, Southern Illinois University

Editors: Lewis J Kaplan, MD, FACS, FCCM, FCCP, Director, SICU and Surgical Critical Care Fellowship, Associate Professor, Department of Surgery, Section of Trauma, Surgical Critical Care, and Surgical Emergencies, Yale University School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; David L Morris, MD, PhD, Professor, Department of Surgery, St George Hospital, University of New South Wales, Australia; Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy; John Geibel, MD, DSc, MA, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital

Author and Editor Disclosure

Synonyms and related keywords: RVF, RVFs, anovaginal fistulas, obstetric injury, radiation injury, inflammatory bowel disease, IBD, Crohn disease, operative trauma, perineal lacerations, forceful coitus, ulcerative colitis, perirectal abscess, diverticulitis, tuberculosis, lymphogranuloma venereum, Bartholin gland abscess, vaginitis, cystitis, sigmoid-vaginal cuff fistulas, proctosigmoidoscopy, sigmoidoscopy, colonoscopy, colostomy

History of the Procedure

For thousands of years, women simply tolerated the distressing symptoms generated by rectovaginal fistulas (RVFs). This is no longer necessary because most RVFs can be surgically corrected via a number of approaches. A small percentage cannot be corrected because of patient comorbidity or disease-related factors; these unfortunate patients can be helped only by fecal diversion.

Problem

RVFs are epithelial-lined tracts between the rectum and vagina. This article discusses only acquired RVFs. Most RVFs are located at or just above the dentate line. Fistulas below the dentate line are not true RVFs; these are anovaginal fistulas, and they are treated differently.

Frequency

Frequency varies among reported series according to etiology. RVFs are classified on the basis of location, size, and etiology, each of which affects the treatment plan and prognosis. Low RVFs are closest to the anus and can be corrected with a perineal approach. High fistulas require a transabdominal approach for repair.

A more precise definition is that a low RVF is between the lower third of the rectum and the lower half of the vagina, and a high fistula is between the middle third of the rectum and the posterior vaginal fornix. RVFs may vary greatly in size, but most are less than 2 cm in diameter. Small-sized fistulas are less than 0.5 cm in diameter, medium-sized fistulas are 0.5-2.5 cm, and large-sized fistulas exceed 2.5 cm.

Etiology

The most common etiology is obstetric injury, followed by radiation injury, inflammatory bowel disease ([IBD], most often Crohn disease), operative trauma, infectious etiologies, and neoplasm.

Pathophysiology

Several traumatic causes of RVF exist. Perineal lacerations during childbirth, especially those due to episioproctotomy, predispose patients to RVFs. Perineal lacerations are more common in primigravidas, in precipitous births, or when forceps or vacuum extraction is used. Failure to recognize and correctly repair perineal lacerations, or secondary infection of perineal lacerations, further increases the chance of RVF. Prolonged labor with pressure on the rectovaginal septum can produce necrosis and result in RVF. Vaginal or rectal operative procedures, especially those performed near the dentate line, may cause RVFs. Pelvic operations can be complicated by the development of a high RVF. Traumatic injury (penetrating or blunt) and forceful coitus have produced RVFs.

Both Crohn disease and, less often, ulcerative colitis have been associated with RVFs. The fistula may arise primarily or, more often, in relation to a perirectal abscess and/or fistula, manifesting as complicated perianal sepsis.

Radiation used in the treatment of pelvic malignancies may result in RVF. Fistulas that occur during therapy are usually due to tumor regression. Most other fistulas become apparent 6 months to 2 years after completion of therapy. Diabetes, hypertension, smoking, and previous abdominal or pelvic surgery increase the risk of fistula formation. Differentiating radiation change at the fistula from a recurrent tumor by biopsy is imperative because neoplasms (primary, recurrent, metastatic) can produce RVFs.

A variety of infectious conditions can produce RVF. The most common are perirectal abscess/fistula and diverticulitis. Less common conditions are tuberculosis, lymphogranuloma venereum, and Bartholin gland abscess.

Clinical

The clinical presentation of RVFs varies little. A few patients are asymptomatic. Most patients report passage of flatus or stool through the vagina, which is understandably distressing. Patients may also experience vaginitis or cystitis. At times, a foul-smelling vaginal discharge develops, but frank stool per vagina usually occurs only when the patient has diarrhea. The clinical picture may include fecal incontinence due to associated anal sphincter damage or bloody, mucous-rich diarrhea caused by the underlying clinical etiology.



Because the symptoms of RVFs are so distressing, surgical therapy is almost always indicated. Exceptions include patients who are moribund or those with prohibitive risks for the proposed anesthesia and surgery. Note that surgical therapy means repair in most cases. Some patients are better served by a diverting stoma than an ill-advised repair attempt.



The rectovaginal septum is the thin septum separating the anterior rectal wall and the posterior vaginal wall. The caudal portion of the septum is the perineal body. The anal sphincters are located in the posterior portion of the perineal body. The transverse perinei muscle traverses the perineal body and is often used in anal sphincteroplasty and RVF repair.

The dentate line is the grossly visible demarcation between the squamous anal epithelium and the transitional-columnar epithelium of the rectum. The anal glands open into the bases of the anal crypts at this location.

The lowest extent of the peritoneal cavity in the female lies in the pelvis and may be anterior to the cervix uteri, posterior to the cervix uteri, or both. Occupation of this space by the small bowel is termed an enterocele. Occupation of this space by the sigmoid colon is termed a sigmoidocele.



See Medical therapy and Intraoperative details.



Lab Studies

  • Laboratory studies (eg, CBC count, blood cultures, electrolytes, BUN, creatinine, type and screen) are obtained to assess for sepsis, which is extremely rare in fistulas between the GI and female genital tracts. Laboratory studies are also helpful to establish preoperative baselines.

Imaging Studies

  • Ancillary studies may illustrate a fistula that is elusive on physical examination.
    • Barium enema can demonstrate RVF or the more common sigmoid-vaginal cuff fistula observed in diverticulitis. (See Diverticulitis of sigmoid-vaginal cuff fistulas).
    • CT scan often shows perifistular inflammation, identifying the responsible digestive organ.

Other Tests

  • Physical examination is essential. This usually confirms the diagnosis and affords much information regarding the size and location of the fistula, the function of the sphincters, and the possibility of IBD or local neoplasm.
  • Office examination usually consists of a rectovaginal examination (visual and palpation) and proctosigmoidoscopy. The fistula opening may be seen as a small dimple or pit and occasionally can be gently probed for confirmation.
  • The suspicion of Crohn disease should be high if there is any other abnormality of the rectal mucosa or a previous or currently coexisting fistula in ano. Failure to recognize Crohn disease can lead to inappropriate operative intervention and can worsen the patient's situation.
  • Placing a vaginal tampon, instilling methylene blue into the rectum, and examining the tampon after 15-20 minutes can often establish the presence of RVF. If the tampon is unstained, another part of the GI tract may be involved.

Diagnostic Procedures

  • Flexible endoscopy (sigmoidoscopy or colonoscopy) is used to fully evaluate the possibility of IBD. When IBD is in the differential diagnosis, endoscopy with biopsies must precede any operative approach to the fistula because the treatment varies, depending upon the diagnosis.

Histologic Findings

Histology is most important in the evaluation of possible IBD. Neither a diagnosis of ulcerative colitis nor a diagnosis of Crohn disease completely excludes operative repair of RVF, but operative planning is altered, as is the prognosis. If the rectum is grossly normal in Crohn disease, the prognosis of RVF repair is fair. When the rectum is abnormal, prognosis is considerably worse. The histopathology of any fistula considered suggestive of primary or recurrent neoplasm is of the utmost importance.



Medical therapy

Treat acute fistulas of traumatic origin (including those caused by obstetric and operative trauma) and fistulas complicated by secondary infection or of infectious origin with local care, drainage of abscesses, and directed antibiotic therapy. Allow tissues to heal for 6-12 weeks. Dietary modification and supplemental fiber can greatly diminish symptoms during this period. Many fistulas resulting from obstetric or operative trauma heal completely, requiring no further therapy. When the fistula persists after this period of treatment, and the tissues become uninflamed and supple, repair may be considered.

Perform a biopsy on any area suggestive of neoplasm. Treat neoplasms as appropriate. In this setting, very symptomatic fistulas may prompt the physician and patient to consider a diverting colostomy for patient comfort. Otherwise, fecal diversion is rarely used with RVFs.

If evaluation is consistent with the diagnosis of IBD, institute appropriate medical therapy. Repair of an RVF can be performed while the patient is on steroids, with the understanding that the risk of failure is increased. Even after initial failed repair attempts, some patients with Crohn disease can maintain RVF repair while on antimetabolites such as 6-mercaptopurine or azathioprine (Imuran). Clinical use of infliximab (Remicade) suggests that few fistulas heal completely, but most patients are dramatically improved symptomatically. Predictors of failure requiring fecal diversion have been identified and include significant colonic involvement and the presence of anal stricture. The development of carcinoma has been described in Crohn fistulas.

RVFs of radiation origin are very difficult to treat surgically, and medical therapy is often initially recommended in this setting. Diet and fiber are the mainstays of therapy.

Surgical therapy

See Intraoperative details.

Preoperative details

Complete mechanical bowel preparation is essential for transabdominal repairs of RVFs and is also recommended for local repairs. The practice of including poorly absorbed oral antibiotics in the bowel preparation is under scrutiny. New data suggest that intravenous antibiotics administered in a manner to provide appropriate tissue levels at the beginning of the operative procedure are sufficient for prophylaxis. The author recommends that prophylactic intravenous antibiotics be administered preoperatively for all patients undergoing RVF repairs, transabdominal or local.

Although used in the past, the overwhelming majority of RVFs are now repaired without first performing a diverting colostomy.

Cleanse the vaginal lumen with an antiseptic solution such as Betadine. Insert a catheter into the urinary bladder.

If a transabdominal procedure is planned, perform standard preoperative cardiopulmonary evaluation as appropriate. Prophylaxis against venous thromboembolism is essential and may include fractionated or unfractionated heparin as well as sequential compression devices. If the pelvis has been radiated or previously operated upon, the use of ureteral catheters may aid in dissection. A laparoscopic approach has been described.

Intraoperative details

Local repair methods

  • Transanal advancement flap repair: The best results have been reported with this type of repair. General, regional, or local anesthesia may be used. The patient is placed in the prone, flexed position with a hip roll in place; buttocks are taped apart for exposure. The fistula is identified using the operating anoscope. A flap is outlined, extending at least 4 cm cephalad to the fistula, with the base of the flap twice the width of the apex to allow adequate blood supply to the flap tip. Local anesthetic with epinephrine is injected submucosally to facilitate raising the flap and to diminish bleeding.
  • The flap is raised, consisting of mucosa and submucosa; some surgeons include circular muscle as well. Meticulous hemostasis is imperative. The fistula tract is curetted gently. Circular muscle is closed over the fistula. The tip of the flap, which includes the fistula opening, is excised. The flap is sutured in place with simple interrupted absorbable sutures, effectively closing the rectal opening of the fistula. The vaginal side of the fistula is left open for drainage. This approach separates the suture line from the fistula site and interposes healthy muscle between the rectal and vaginal walls. Proponents point out that the relatively high pressure within the rectum serves to buttress the repair in contrast to a transvaginal repair, in which the intrarectal pressure is more prone to disrupt the repair. If indicated, sphincteroplasty can also be performed concomitantly.
  • Transvaginal inversion repair: The vaginal mucosa is circumferentially elevated, exposing the fistula. Two or 3 concentric pursestring sutures are used to invert the fistula into the rectal lumen. The vaginal mucosa is reapproximated. This approach, suitable only for small, low fistulas in otherwise healthy tissues with an intact perineal body, is rarely performed today.
  • Conversion to complete perineal laceration with layer closure: The fistulous tract is laid open in the midline, essentially creating a cloaca. Closure in layers follows, identical to the classic obstetric repair of a fourth-degree perineal laceration. This method is described in the gynecologic literature; it is rarely employed by colorectal surgeons because of concerns of juxtaposed suture lines.
  • Simple fistulotomy: This procedure works well for true anovaginal fistulas, in which no sphincter is involved in the tract. However, if used to treat an RVF, partial or total fecal incontinence results.

Transabdominal approaches

Transabdominal approaches are generally used for high RVFs when the fistula originates from a neoplasm, radiation, or, occasionally, IBD. They are also used if concomitant disease (eg, diverticulitis) warrants an abdominal approach.

  • Fistula division and closure without bowel resection: This is the simplest abdominal approach. The rectovaginal septum is dissected, the fistula is divided, and the rectum and vagina are closed primarily without bowel resection. Interposition of healthy tissue, such as omentum, may be used to buttress the repair and separate the suture lines. Good results have been reported when the fistula is not large and the tissues available for closure are healthy.
  • Bowel resection: When tissues are abnormal because of radiation, inflammation, or neoplasm, the repair is doomed to failure unless the abnormal tissues are resected. Preserve functional anal sphincters whenever possible by use of a low anterior resection, a coloanal anastomosis technique, or a pull-through; the last has the poorest results with respect to continence. Rarely, abdominoperineal resection may be necessary for symptom control in the setting of radiation damage or neoplasm. An alternative, particularly in cases of poor operative risks or with patients whose survival is limited, is simple fecal diversion with a loop ileostomy or colostomy.
  • Ancillary procedures: A host of supplementary procedures have been described to augment bowel resection in the difficult pelvis. These include local flaps, such as the bulbocavernosus flap, and a variety of muscle, fascial, and musculocutaneous flaps for repair of large pelvic defects. A variety of graft procedures have also been described. All of these procedures have the goal of interposing healthy tissue between vaginal and rectal repairs. These are well described in the plastic surgery literature.

Postoperative details

  • Local repairs: Pay attention to the patient's bowel habits. Constipation or diarrhea can disrupt a repair. The goal is a soft, formed, deformable stool. The patient is carefully counseled regarding diet, copious fluid intake, and use of stool softeners. Use of bulking agents immediately after repair is at the discretion of the surgeon and is a matter of individual preference rather than scientifically proven practice. Use of oral antibiotics also varies. The author prefers that patients use an oral broad-spectrum antibiotic for 3-5 days postoperatively, take 1 tablespoon of mineral oil orally bid for 2 weeks postoperatively, and avoid bulking agents for 2 weeks postoperatively.
  • Abdominal repairs: Postoperative care is identical to the care administered to all patients who have undergone major laparotomy with bowel resection and anastomosis. Postoperative gastric decompression is performed selectively, expecting that 15-20% of patients require cessation of oral intake or gastric decompression for symptomatic postoperative ileus. Most patients can be offered sips of clear liquids on the first postoperative day. Early ambulation is beneficial in many ways. Continue perioperative prophylaxis for thromboembolic events until the patient is ambulating well.

Follow-up

Patients are seen 2 weeks after discharge for evaluation of wounds and bowel habits. In the absence of recurrent fistula symptoms or other specific indications, no follow-up investigation, aside from physical examination, is required. Specific signs and symptoms are investigated appropriately. For example, fever, diarrhea, and low abdominal pain indicating an abscess are evaluated by a CT scan of the abdomen and pelvis. In this setting, physical examination may be difficult because of patient discomfort.



Complications of local repairs

Bleeding is rarely encountered postoperatively, probably because of careful intraoperative hemostasis. If bleeding occurs beneath the flap, fistula recurrence is common. Infection is a feared complication because it almost invariably results in a failed repair. However, good data on the incidence of infection after local repair are few. Of course, repairs may fail in the absence of infection as well (see Outcome and Prognosis). Rarely, postoperative pain precipitates urinary retention.

Complications of transabdominal repairs

These may include the usual complications of any laparotomy with bowel resection, including fistula recurrence. The most common complications are bleeding and wound infection, each with an incidence of less than 2-5% in reasonable-risk candidates. Pelvic abscess occurs in 5-7% of patients. Anastomotic leaks probably occur more often than is clinically recognized based on recent data from the United States and Europe. However, because intervention is indicated only in clinically evident leaks, routine postoperative anastomotic evaluation is not warranted.



Local repair methods

  • Transanal advancement flap repair: This approach is very safe. Results are good to excellent, with success reported in 77-100% of patients in various series. More recent reports note the importance of preoperative assessment of anal sphincter integrity. Sphincter repair is easily performed simultaneously and increases the success rate of RVF repair. Vaginal childbirth after RVF repair is not associated with increased risk of RVF recurrence. However, if a sphincter repair is performed along with the RVF repair, many surgeons recommend cesarean delivery for subsequent pregnancies in order to avoid disruption of the sphincteroplasty.
  • Transvaginal inversion repair and conversion to complete perineal laceration with layer closure: Results with these approaches can be acceptable in selected cases, as noted in the section on surgical approaches. The author's preference is to proceed with transanal advancement flap repair at the first repair attempt.
  • Simple fistulotomy: As noted, this is suitable for true anovaginal fistulas only, which incorporate no sphincter muscle whatsoever. Application of this approach to RVF results in incontinence.

Transabdominal approaches

With approximation of healthy tissue in the absence of inflammation, infection, or tension, transabdominal repairs yield good long-term results. Always consider the morbidities of major abdominal surgery and any coexistent morbidities related to the patient's history.

Patients with fistulas due to radiation may have added morbidities associated with other irradiated tissues. These morbidities include (1) cystitis; (2) ureteral complications, including stricture and obstruction; (3) vascular injury, including stenosis and occlusion; (4) small bowel injury, including stricture, malabsorption, and obstruction; (5) neurologic complications; and (6) bony complications, including necrosis and fractures.

Prognosis of recurrent RVFs

Recurrence confers a poorer prognosis for future repair attempts. Recurrence is influenced by the etiology of the fistula as well as its complexity. Fistulas of obstetric origin and fistulas that are considered simple (rather than complex) fare better after repeated repair attempts.



Crohn disease

RVFs associated with Crohn disease are difficult to manage. When symptoms are few, operative intervention may not be indicated. Conversely, severely symptomatic patients may require proctectomy. Patients with relatively normal rectal mucosa and an RVF are good candidates for an endorectal advancement flap. In this specific setting, outcome is good, though it is not as good as in patients without Crohn disease. An endorectal advancement flap is considered the preferred technique for local RVF repair in patients with Crohn disease and a relatively normal rectum. The author has had experience treating patients with Crohn disease, an RVF, and a relatively normal rectum with 6-mercaptopurine for several months and then performing an endorectal advancement flap repair with good results in a small series.

Bricker patch

The on-lay Bricker patch has been used for repair of RVFs that are chiefly due to radiation. Briefly summarized, the rectosigmoid colon is mobilized transabdominally, and the RVF is exposed. The rectosigmoid is divided above the fistula. The proximal end is brought out as an end sigmoid colostomy. The distal rectosigmoid is turned down and the open end anastomosed to the debrided edge of the rectal opening of the fistula, essentially creating an internal loop with drainage through the anus. When healing of the inferior-patched rectum can be demonstrated radiologically several months later, continuity of the colon is reestablished by anastomosis of the colostomy to the apex of the patch loop in an end-to-side fashion.

Advantages may include less difficulty than with resection approaches; therefore, less morbidity of hemorrhage and organ injury occurs. Disadvantages include the radiation-damaged rectum being left in place and in use, with the possibility of further morbidity, including bleeding and stricture.

Although situations in which this approach may be preferable to a resection approach exist, the author believes that resection of the radiation-damaged bowel provides the best long-term results in patients who are reasonable operative candidates.



  • Bangser M. Obstetric fistula and stigma. Lancet. Feb 11 2006;367(9509):535-6. [Medline].
  • Bricker EM, Johnston WD. Repair of postirradiation rectovaginal fistula and stricture. Surg Gynecol Obstet. Apr 1979;148(4):499-506. [Medline].
  • Burke C. Rectovaginal fistulas. Clin J Oncol Nurs. Jun 2005;9(3):295-7. [Medline].
  • Casadesus D, Villasana L, Sanchez IM, et al. Treatment of rectovaginal fistula: a 5-year review. Aust N Z J Obstet Gynaecol. Feb 2006;46(1):49-51. [Medline].
  • Cohen JL, Stricker JW, Schoetz DJ, et al. Rectovaginal fistula in Crohn''s disease. Dis Colon Rectum. Oct 1989;32(10):825-8. [Medline].
  • Fry RD, Kodner IJ. Rectovaginal fistula. Surg Annu. 1995;27:113-31. [Medline].
  • Galandiuk S, Kimberling J, Al-Mishlab TG, et al. Perianal Crohn disease: predictors of need for permanent diversion. Ann Surg. May 2005;241(5):796-801; discussion 801-2. [Medline].
  • Gonzalez-Lama Y, Abreu L, Vera MI, et al. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study. Inflamm Bowel Dis. Jan 2005;11(1):8-15. [Medline].
  • Hilger WS, Cornella JL. Rectovaginal fistula after Posterior Intravaginal Slingplasty and polypropylene mesh augmented rectocele repair. Int Urogynecol J Pelvic Floor Dysfunct. Jan 2006;17(1):89-92. [Medline].
  • Husain A, Johnson K, Glowacki CA, et al. Surgical management of complex obstetric fistula in Eritrea. J Womens Health (Larchmt). Nov 2005;14(9):839-44. [Medline].
  • Jasonni VM, La Marca A, Manenti A. Rectovaginal fistula repair using fascia graft of autologous abdominal muscles. Int J Gynaecol Obstet. Jan 2006;92(1):85-6. [Medline].
  • Khanduja KS, Yamashita HJ, Wise WE Jr. Delayed repair of obstetric injuries of the anorectum and vagina. A stratified surgical approach. Dis Colon Rectum. Apr 1994;37(4):344-9. [Medline].
  • Kumaran SS, Palanivelu C, Kavalakat AJ, et al. Laparoscopic repair of high rectovaginal fistula: is it technically feasible?. BMC Surg. 2005;5:20. [Medline].
  • Laurent S, Barbeaux A, Detroz B, et al. Development of adenocarcinoma in chronic fistula in Crohn''s disease. Acta Gastroenterol Belg. Jan-Mar 2005;68(1):98-100. [Medline].
  • MacRae HM, McLeod RS, Cohen Z. Treatment of rectovaginal fistulas that has failed previous repair attempts. Dis Colon Rectum. Sep 1995;38(9):921-5. [Medline].
  • Miklos JR, Kohli N. Rectovaginal fistula repair utilizing a cadaveric dermal allograft. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(6):405-6. [Medline].
  • Moore RD, Miklos JR, Kohli N. Rectovaginal fistula repair using a porcine dermal graft. Obstet Gynecol. Nov 2004;104(5 Pt 2):1165-7. [Medline].
  • Nowacki MP. Ten years of experience with Parks'' coloanal sleeve anastomosis for the treatment of post-irradiation rectovaginal fistula. Eur J Surg Oncol. Dec 1991;17(6):563-6. [Medline].
  • Steichen FM, Barber HK, Loubeau JM, et al. Bricker-Johnston sigmoid colon graft for repair of postradiation rectovaginal fistula and stricture performed with mechanical sutures. Dis Colon Rectum. Jun 1992;35(6):599-603. [Medline].
  • Tsang CB, Rothenberger DA. Rectovaginal fistulas. Therapeutic options. Surg Clin North Am. Feb 1997;77(1):95-114. [Medline].
  • Tsang CB, Madoff RD, Wong WD. Anal sphincter integrity and function influences outcome in rectovaginal fistula repair. Dis Colon Rectum. Sep 1998;41(9):1141-6. [Medline].

Rectovaginal Fistula excerpt

Article Last Updated: Aug 3, 2006